Outcome at age 4 years in offspring of women with maternal phenylketonuria: The Maternal PKU Collaborative Study

JAMA

Volumn 283, Issue 6, 2000, Pages 756-762

  Waisbren, Susan E ^a   Hanley, William ^b   Levy, Harvey L ^a   Shifrin, Harvey ^c   Allred, Elizabeth ^a   Azen, Colleen ^d   Chang, Pi Nian ^e   Cipeic Schmidt, Sanja ^f   De La Cruz, Felix ^c   Hall, Ramona ^d   Matalon, Reuben ^g   Nanson, Jo ^h   Rouse, Bobbye ^g   Trefz, Fritz ⁱ   Koch, Richard ^d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^h ROYAL UNIVERSITY HOSPITAL   (Canada)

ⁱ General Hospital Reutlingen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

ADAPTIVE BEHAVIOR; ARTICLE; BIRTH ORDER; CANADA; CHILD BEHAVIOR; COGNITION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DIET THERAPY; FEMALE; FETUS OUTCOME; GERMANY; HUMAN; HYPERPHENYLALANINEMIA; INTELLIGENCE QUOTIENT; LANGUAGE DEVELOPMENT; MAJOR CLINICAL STUDY; MATERNAL DISEASE; PHENYLKETONURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; UNITED STATES;

EID: 0033950629     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.6.756     Document Type: Article

References (35)

1. Lenke RR, Levy HL. Maternal phenylketonuria and hyperphenylalaninemia: an international survey of the outcome of untreated and treated pregnancies. N Engl J Med. 1980;303:1202-1208.
2. Ghavami M, Levy HL. Prevention of fetal damage through dietary control of maternal hyperphenylalaninemia. Clin Obstet Gynecol. 1986;29:580-585.
3. Platt LD, Koch R, Azen C, et al. Maternal phenylketonuria collaborative study, obstetric aspects and outcome: the first 6 years. Am J Obstet Gynecol. 1992; 166:1150-1160.
4. Levy HL, Ghavami M. Maternal phenylketonuria: a metabolic teratogen. Teratology. 1996;53:176-184.
5. Lynch BC, Pitt DB, Maddison TG, et al. Maternal phenylketonuria: successful outcome in four pregnancies treated prior to conception. Eur J Pediatr. 1988; 148:72-75.
6. Acosta PB, Blaskovics M, Cloud H, et al. Nutrition in pregnancy of women with hyperphenylalaninemia. J Am Diet Assoc. 1982;80:443-450.
7. Hanley WB, Clarke JTR, Schoonheyt WE Maternal phenylketonuria (PKU): a review. Clin Biochem. 1987;20:149-156.
8. Koch R, Friedman E, Azen C, et al. International Collaborative Study of Maternal Phenylketonuria Status Report 1998. Ment Retard Dev Dis Rev. 1999;5: 117-121.
9. Michals K, Acosta PB, Austin V, et al. Nutrition and reproductive outcome in maternal phenylketonuria. Eur J Pediatr. 1996;155(suppl 1):165-168.
10. Guldberg P, Rey F, Zschocke J, et al. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet. 1998;63: 71-79.
11. Rouse B, Azen C, Koch R, et al. Maternal Phenylketonuria Collaborative Study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae. Am J Med Genet. 1997;69:89-95.
12. Matalon R, Michals K, Azen C, et al. Maternal PKU Collaborative Study: pregnancy outcome and postnatal head growth. J Inherit Metab Dis. 1994;17:353-355.
13. Waisbren SE, Chang P, Levy HL, et al. Neonatal neurological assessment of offspring in maternal phenylketonuria. J Inherit Metab Dis. 1998;21:39-48.
14. Hanley WB, Koch R, Levy et al. The North American Maternal Phenylketonuria Collaborative Study: develomental assessment of the offspring: preliminary report, Eur J Pediatr. 1996;155(suppl 1):169-172.
15. McCarthy D. McCarthy Scales of Children's Abilities. New York, NY: Psychological Corp: 1972.
16. Thompson RJ, Gustafson KE, Oehler JM, Catlett AT, Brazy JE, Goldstein RF. Developmental outcome of very low birth weight infants at four years of age as a function of biological risk and psychosocial risk. J Dev Behav Pediatr. 1997;18:91-96.
17. Fried PA, O'Connell CM, Watkinson B. 60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment. J Dev Behav Pediatr. 1992;13: 383-391.
18. Newcomer PL, Hammill DD. Test of Language Development-Primary. 2nd ed. Austin, Tex: PRO-ED; 1991.
19. Achenbach TM. Manual for the Child Behavior Checklist/4-18 and 1991 Profile. Burlington: University of Vermont Dep of Psychiatry; 1991.
20. Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behavior Scales Circle Pines, Minn: American Guidance Service; 1984.
21. Caldwell BM, Bradley RH. Home Observation for Measurement of the Environment. Little Rock: University of Arkansas, College of Education, Center for Child Development and Education; 1984.
22. Wechsler D. Wechsler Adult Intelligence Scale-Revised. Cleveland, Ohio: The Psychological Corp; 1981.
23. Hollingshead AB, Redlich FC. Two Factor Index of Social Position. Available from: AB Hollingshead, 1965 Yale Station, New Haven, CT 06520.
24. Wilkinson I. Systat: The System for Statistics. Evanston, Ill: Systat Inc; 1990.
25. STATA Corporation. Stata Statistical Software, Release 4.0. College Station, Tex: Stata Corp; 1995.
26. Waisbren SE, Brown MJ, de Sonneville LMJ, Levy HL. Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr Suppl. 1994;408:98-103.
27. Lipson A, Beuhler B, Bartley J, et al. Maternal hyperphenylalaninemia fetal effects. J Pediatr. 1984; 104:216-220.
28. Janzen LA, Nanson JL, Block GW. Neuropsychological evaluation of preschoolers with fetal alcohol syndrome. Neurotoxicol Teratol. 1995;17:273-279.
29. Spohr HL, Willims J, Steinhausen HC. Prenatal alcohol exposure and long-term developmental consequences. Lancet. 1993;341:907-910.
30. Waisbren SE, Shiloh S, St James PJ, Levy HL. Psychosocial factors in maternal phenylketonuria: prevention of unplanned pregnancies. Am J Public Health, 1991;81:299-304.
31. Waisbren SE, Rokni H, Bailey I, et al. Social factors and the meaning of food in adherence to medical diets: results of a maternal phenylketonuria summer camp. J Inherit Metab Dis. 1997;20:21-27.
32. Levy HL, Waisbren SE. PKU in adolescents: rationale and psychosocial factors in diet continuation. Acta Paediatr Suppl. 1994;407:92-97.
33. Doran GP, Rohr FJ, Slonim A, Güttler F, Levy HL. Necessity of complete intake of phenylalanine-free amino acid mixture for metabolic control of phenyl-ketonuria. J Am Diet Assoc 1999;99:1559-1563.
34. Kecskemethy HH, Lobbregt L, Levy HL. The use of gelatin capsules for ingestion of formula in dietary treatment of maternal phenylketonuria. J Inherit Metab Dis. 1993;16:111-118.
35. St James PL, Shapiro E, Waisbren SE. The Maternal PKU Resource Mothers Program. Am J Public Health. 1999;89:762-764.